Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anika Therapeutics, Inc. stock logo
ANIK
Anika Therapeutics
$26.68
+4.0%
$25.81
$16.54
$28.67
$395.66M0.8474,716 shs70,573 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$31.93
+1.1%
$30.73
$23.10
$48.47
$760.89M1.18171,302 shs96,252 shs
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$78.55
-0.4%
$70.37
$44.27
$81.68
$1.76B0.89119,298 shs126,463 shs
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$4.71
-0.4%
$5.42
$4.38
$8.45
$348.35M0.23867,741 shs906,473 shs
Surmodics, Inc. stock logo
SRDX
Surmodics
$42.05
0.0%
$30.88
$18.51
$42.36
$599.63M1.17110,845 shs648,376 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anika Therapeutics, Inc. stock logo
ANIK
Anika Therapeutics
0.00%+4.40%-7.03%-1.38%-5.94%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.00%-2.95%-3.81%+14.09%-30.21%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
0.00%-1.09%+6.28%+16.14%+21.52%
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
0.00%-2.47%-13.84%-31.35%-17.31%
Surmodics, Inc. stock logo
SRDX
Surmodics
0.00%+22.34%+29.46%+32.93%+121.14%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Anika Therapeutics, Inc. stock logo
ANIK
Anika Therapeutics
3.2035 of 5 stars
2.31.00.03.62.41.71.9
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
3.936 of 5 stars
3.41.00.03.93.34.20.0
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
4.1003 of 5 stars
2.43.03.30.03.83.32.5
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
4.1977 of 5 stars
3.21.00.04.23.81.71.9
Surmodics, Inc. stock logo
SRDX
Surmodics
3.0596 of 5 stars
2.02.00.03.41.91.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Anika Therapeutics, Inc. stock logo
ANIK
Anika Therapeutics
2.50
Moderate Buy$30.5014.32% Upside
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
2.75
Moderate Buy$45.5042.50% Upside
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2.89
Moderate Buy$77.57-1.25% Downside
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
2.33
Hold$6.6340.66% Upside
Surmodics, Inc. stock logo
SRDX
Surmodics
2.00
Hold$50.0018.91% Upside

Current Analyst Ratings

Latest ANIK, SRDX, LMAT, KIDS, and OSUR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/31/2024
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/31/2024
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$100.00
5/30/2024
Surmodics, Inc. stock logo
SRDX
Surmodics
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform
5/29/2024
Anika Therapeutics, Inc. stock logo
ANIK
Anika Therapeutics
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$24.00 ➝ $24.00
5/29/2024
Surmodics, Inc. stock logo
SRDX
Surmodics
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$43.00
5/29/2024
Surmodics, Inc. stock logo
SRDX
Surmodics
Sidoti
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral$43.00
5/29/2024
Surmodics, Inc. stock logo
SRDX
Surmodics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
5/13/2024
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$7.00 ➝ $6.00
5/9/2024
Anika Therapeutics, Inc. stock logo
ANIK
Anika Therapeutics
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$37.00 ➝ $37.00
5/8/2024
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$35.00 ➝ $38.00
5/7/2024
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$37.00 ➝ $42.00
(Data available from 6/3/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Anika Therapeutics, Inc. stock logo
ANIK
Anika Therapeutics
$166.66M2.37$5.12 per share5.21$14.50 per share1.84
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$148.73M5.12N/AN/A$16.14 per share1.98
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$193.48M9.11$1.78 per share44.17$13.38 per share5.87
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$304.64M1.14$1.33 per share3.53$5.86 per share0.80
Surmodics, Inc. stock logo
SRDX
Surmodics
$132.58M4.52$0.78 per share53.64$8.48 per share4.96

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Anika Therapeutics, Inc. stock logo
ANIK
Anika Therapeutics
-$82.67M-$5.25N/A20.212.38-45.39%0.48%0.39%8/13/2024 (Estimated)
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$20.97M-$0.96N/AN/AN/A-13.58%-5.12%-4.41%7/29/2024 (Estimated)
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$30.10M$1.5152.0239.872.4016.99%11.57%10.02%8/6/2024 (Estimated)
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$53.65M$0.3015.70N/AN/A7.50%7.68%6.83%8/1/2024 (Estimated)
Surmodics, Inc. stock logo
SRDX
Surmodics
-$1.54M$0.9544.26841.00N/A9.44%13.30%8.63%8/7/2024 (Estimated)

Latest ANIK, SRDX, LMAT, KIDS, and OSUR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024Q1 2024
Anika Therapeutics, Inc. stock logo
ANIK
Anika Therapeutics
$0.13$0.09-$0.04$0.49$39.23 million$40.52 million
5/8/2024Q1 2024
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$0.04$0.04N/A$0.05$52.27 million$54.10 million    
5/6/2024Q1 2024
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.42-$0.30+$0.12-$0.26$41.63 million$44.69 million
5/2/2024Q1 2024
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$0.39$0.44+$0.05$0.44$51.50 million$53.48 million    
5/1/2024Q2 2024
Surmodics, Inc. stock logo
SRDX
Surmodics
-$0.36$0.07+$0.43$0.12$28.79 million$31.96 million    
3/13/2024Q4 2023
Anika Therapeutics, Inc. stock logo
ANIK
Anika Therapeutics
-$0.15$0.05+$0.20$4.40$41.51 million$42.97 million
3/6/2024Q4 2023
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.28-$0.23+$0.05-$0.17$37.59 million$37.61 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Anika Therapeutics, Inc. stock logo
ANIK
Anika Therapeutics
N/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
N/AN/AN/AN/AN/A
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$0.640.81%+13.80%42.38%13 Years
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
N/AN/AN/AN/AN/A
Surmodics, Inc. stock logo
SRDX
Surmodics
N/AN/AN/AN/AN/A

Latest ANIK, SRDX, LMAT, KIDS, and OSUR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/30/2024
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
Quarterly$0.160.86%5/15/20245/16/20245/30/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Anika Therapeutics, Inc. stock logo
ANIK
Anika Therapeutics
N/A
5.59
3.85
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.03
4.45
1.99
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
N/A
7.57
5.31
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
N/A
11.97
10.49
Surmodics, Inc. stock logo
SRDX
Surmodics
0.24
4.39
3.59

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Anika Therapeutics, Inc. stock logo
ANIK
Anika Therapeutics
91.53%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
69.05%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
84.64%
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
93.50%
Surmodics, Inc. stock logo
SRDX
Surmodics
96.63%

Insider Ownership

CompanyInsider Ownership
Anika Therapeutics, Inc. stock logo
ANIK
Anika Therapeutics
5.85%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
31.80%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
10.79%
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
3.40%
Surmodics, Inc. stock logo
SRDX
Surmodics
8.90%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Anika Therapeutics, Inc. stock logo
ANIK
Anika Therapeutics
35714.83 million13.96 millionOptionable
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
24723.83 million16.25 millionOptionable
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
61422.45 million20.02 millionOptionable
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
63873.96 million71.44 millionOptionable
Surmodics, Inc. stock logo
SRDX
Surmodics
37614.26 million12.99 millionOptionable

ANIK, SRDX, LMAT, KIDS, and OSUR Headlines

Recent News About These Companies

Surmodics (NASDAQ:SRDX) Stock Rating Lowered by StockNews.com
Surmodics (NASDAQ:SRDX) Rating Reiterated by Needham & Company LLC
Sidoti Reiterates "Neutral" Rating for Surmodics (NASDAQ:SRDX)
Surmodics Going Private in $627M Deal
GTCR To Acquire Surmodics - Quick Facts

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Anika Therapeutics logo

Anika Therapeutics

NASDAQ:ANIK
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.
OrthoPediatrics logo

OrthoPediatrics

NASDAQ:KIDS
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
LeMaitre Vascular logo

LeMaitre Vascular

NASDAQ:LMAT
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
OraSure Technologies logo

OraSure Technologies

NASDAQ:OSUR
OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.
Surmodics logo

Surmodics

NASDAQ:SRDX
Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.